What is Homecoming?
Homecoming operates as a patient care platform specifically designed for psychedelic therapy. The company collaborates with a network of psychedelic clinics, licensed therapists, and specialized retreats. Its core function is to provide comprehensive support to clients throughout their therapeutic journey, encompassing pre-session preparation, inter-session continuity, and post-session integration, thereby enhancing the efficacy and accessibility of psychedelic treatments.
How much funding has Homecoming raised?
Homecoming has raised a total of $4M across 1 funding round:
Angel/Seed
$4M
Angel/Seed (2022): $4M, investors not publicly disclosed
What's next for Homecoming?
The recent major strategic investment signals a pivotal growth phase for Homecoming. This capital infusion is likely to fuel the expansion of its platform's capabilities, the broadening of its network of clinical partners, and potentially, further research into optimizing patient outcomes in psychedelic-assisted therapies. The company's focus on the critical pre- and post-session phases positions it to capitalize on the increasing mainstream acceptance and clinical application of psychedelic treatments.
See full Homecoming company page
